A quick test for detecting HPV DNA linked to cervical cancer.
Point of Care HPV 16/18/45 DNA Test for Cervical Cancer
['FUNDING_SBIR_2'] · CROSSLIFE TECHNOLOGIES, INC. · NIH-10930943
This study is working on a quick and easy test that can detect certain types of HPV linked to cervical cancer, so that people can get results in under 30 minutes without needing a lab, making it especially helpful for those in areas with limited access to traditional testing.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CROSSLIFE TECHNOLOGIES, INC. (nih funded) |
| Locations | 1 site (CARLSBAD, UNITED STATES) |
| Trial ID | NIH-10930943 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a rapid point-of-care test that can detect HPV types 16, 18, and 45, which are associated with cervical cancer. The test aims to provide results in under 30 minutes, making it suitable for use in non-laboratory settings and by non-technical personnel. By utilizing a novel chemical reaction, the test promises high sensitivity and specificity similar to existing laboratory assays, but with the convenience of a simple paper-strip readout. This approach addresses the need for effective cervical cancer screening, especially in developing countries where access to traditional testing may be limited.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who are at risk for cervical cancer and may benefit from rapid HPV testing.
Not a fit: Patients who have already been diagnosed with cervical cancer or those who do not have HPV types 16, 18, or 45 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve early detection of cervical cancer, potentially saving lives through timely intervention.
How similar studies have performed: Previous research has shown promise in developing point-of-care tests for HPV, indicating that this approach has potential for success.
Where this research is happening
CARLSBAD, UNITED STATES
- CROSSLIFE TECHNOLOGIES, INC. — CARLSBAD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHO, HYUNDAE — CROSSLIFE TECHNOLOGIES, INC.
- Study coordinator: CHO, HYUNDAE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: cancer biomarkers, cancer markers, Cancers